Skip to content

EBITDA at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$19.57M+3,849%
ICU Medical logo
ICU MedicalICUI
$63.61M+2.0%
Tenet Healthcare logo
Tenet HealthcareTHC
-$7.3M+44.4%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Universal Health Services logo
Universal Health ServicesUHS
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Calculated from Pediatrix Medical Group’s reported figures.

$41.7Mebit+
$6.1MDepreciation Depletion & Amortization
=$47.78M

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's EBITDA?
Pediatrix Medical Group (MD) reported EBITDA of $47.78M in Q1 2026.
How has Pediatrix Medical Group's EBITDA changed year-over-year?
Pediatrix Medical Group's EBITDA increased by 27.6% year-over-year, from $37.43M to $47.78M.
What is the long-term trend for Pediatrix Medical Group's EBITDA?
Over 3 years (2021 to 2025), Pediatrix Medical Group's EBITDA has grown at a -0.6% compound annual growth rate (CAGR), from $235.07M to $230.64M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.